Covered recipient · General Payments record
RYAN SCOTT KING
Allopathic & Osteopathic Physicians Family Medicine
General Payments · PY2023–2024
$635.55
- Reported across 36 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $466.53 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $180.22 | 11 |
| Novo Nordisk AS | $95.89 | 5 |
| Lilly USA, LLC | $52.27 | 3 |
| Exact Sciences Corporation | $37.95 | 2 |
| Amgen Inc. | $32.08 | 2 |
| Acerta Pharma LLC | $30.91 | 2 |
| GlaxoSmithKline, LLC. | $20.28 | 1 |
| EISAI INC. | $16.93 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $8.81 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107466579 | CMS |
| ABBVIE INC. | $17.29 | 01/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107466581 | CMS |
| ABBVIE INC. | $10.95 | 01/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107466583 | CMS |
| ABBVIE INC. | $18.84 | 02/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107466585 | CMS |
| ABBVIE INC. | $20.00 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107466587 | CMS |
| ABBVIE INC. | $27.67 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107466589 | CMS |
| ABBVIE INC. | $20.69 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107466591 | CMS |
| ABBVIE INC. | $13.52 | 06/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107466593 | CMS |
| ABBVIE INC. | $20.94 | 10/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107466595 | CMS |
| ABBVIE INC. | $3.99 | 11/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107466597 | CMS |
| ABBVIE INC. | $17.52 | 11/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1107466599 | CMS |
| Amgen Inc. | $17.23 | 01/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117599186 | CMS |
| Amgen Inc. | $14.85 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117599188 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.70 | 02/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123307436 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.21 | 05/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1123302726 | CMS |
| Eisai Inc. | $16.93 | 06/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1110819649 | CMS |
| Exact Sciences Corporation | $18.24 | 02/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128380924 | CMS |
| Exact Sciences Corporation | $19.71 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1128380928 | CMS |
| GlaxoSmithKline, LLC. | $20.28 | 09/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1116419435 | CMS |
| Lilly USA, LLC | $18.64 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135934872 | CMS |
| Lilly USA, LLC | $15.01 | 11/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135901914 | CMS |
| Lilly USA, LLC | $18.62 | 11/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135901912 | CMS |
| Novo Nordisk Inc | $20.69 | 03/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108565767 | CMS |
| Novo Nordisk Inc | $21.88 | 05/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108568427 | CMS |
| Novo Nordisk Inc | $14.29 | 08/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108569636 | CMS |
| Novo Nordisk Inc | $20.55 | 08/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108568159 | CMS |
| Novo Nordisk Inc | $18.48 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1108572422 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.